Leerink Partnrs Issues Optimistic Estimate for SPRY Earnings
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Leerink Partnrs lifted their Q2 2025 earnings per share estimates for shares of ARS Pharmaceuticals in a report released on Sunday, June 22nd. Leerink Partnrs analyst R. Ruiz now forecasts that the company will earn ($0.42) per share for the quarter, up from their previous estimate of […]
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Leerink Partnrs lifted their Q2 2025 earnings per share estimates for shares of ARS Pharmaceuticals in a report released on Sunday, June 22nd. Leerink Partnrs analyst R. Ruiz now forecasts that the company will earn ($0.42) per share for the quarter, up from their previous estimate of […]
